Major Cough Drop Brand Recalled Over Contamination Fears
Major Cough Drop Brand Recalled Over Contamination Fears...
A nationwide recall of cough drops has sparked concern among consumers after tests revealed potential bacterial contamination. The FDA announced the voluntary recall of ThroatEase Max Strength lozenges late Friday, affecting approximately 2.4 million packages sold in pharmacies and supermarkets since January 2026.
The recall comes after routine testing detected traces of Burkholderia cepacia, a bacteria that poses serious risks to immunocompromised individuals. No illnesses have been reported yet, but health officials warn consumers to immediately stop using the affected products, which were manufactured in a Pennsylvania facility.
Major retailers including CVS, Walgreens, and Walmart have pulled the cough drops from shelves. The recalled batches carry expiration dates between 03/2027 and 06/2027, with UPC codes beginning with 72545. Consumers can return products for full refunds at purchase locations.
The recall is trending today as cold and allergy season peaks across much of the U.S., when cough drop usage typically surges. Social media reactions show particular concern among parents and elderly users, who rely heavily on throat lozenges during spring allergy months.
ThroatEase manufacturer Wellness Pharma stated it's working with the FDA to investigate the contamination source. The company's hotline (1-800-555-0199) and website are providing updated recall information. Health experts recommend switching to alternative brands until the investigation concludes.
This marks the third major OTC medication recall in 2026, following January's children's ibuprofen and March's antacid withdrawals. The pattern has renewed calls for stricter quality control measures in pharmaceutical manufacturing facilities.
